[go: up one dir, main page]

AU2001246494A1 - Condensed thiazolamines and their use as neuropeptide y5 antagonists - Google Patents

Condensed thiazolamines and their use as neuropeptide y5 antagonists

Info

Publication number
AU2001246494A1
AU2001246494A1 AU2001246494A AU4649401A AU2001246494A1 AU 2001246494 A1 AU2001246494 A1 AU 2001246494A1 AU 2001246494 A AU2001246494 A AU 2001246494A AU 4649401 A AU4649401 A AU 4649401A AU 2001246494 A1 AU2001246494 A1 AU 2001246494A1
Authority
AU
Australia
Prior art keywords
thiazolamines
neuropeptide
antagonists
condensed
condensed thiazolamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246494A
Inventor
Marc Gerspacher
Heinrich Rueger
Tibur Schmidlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001246494A1 publication Critical patent/AU2001246494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001246494A 2000-03-03 2001-03-01 Condensed thiazolamines and their use as neuropeptide y5 antagonists Abandoned AU2001246494A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10010475 2000-03-03
DE10010476 2000-03-03
DE10010476 2000-03-03
DE10010475 2000-03-03
PCT/EP2001/002339 WO2001064675A1 (en) 2000-03-03 2001-03-01 Condensed thiazolamines and their use as neuropeptide y5 antagonists

Publications (1)

Publication Number Publication Date
AU2001246494A1 true AU2001246494A1 (en) 2001-09-12

Family

ID=26004675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246494A Abandoned AU2001246494A1 (en) 2000-03-03 2001-03-01 Condensed thiazolamines and their use as neuropeptide y5 antagonists

Country Status (2)

Country Link
AU (1) AU2001246494A1 (en)
WO (1) WO2001064675A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
WO2000064880A1 (en) 1999-04-22 2000-11-02 Synaptic Pharmaceutical Corporation Selective npy (y5) antagonists
DK1194421T3 (en) * 1999-06-30 2006-02-13 Lundbeck & Co As H Selective NPY (Y5) antagonists
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
CN100363362C (en) 2002-02-28 2008-01-23 霍夫曼-拉罗奇有限公司 Thiazole derivatives useful as NPY receptor antagonists
ES2193875B2 (en) 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS.
CN100381429C (en) * 2002-08-07 2008-04-16 霍夫曼-拉罗奇有限公司 Thiazole derivatives
BRPI0413458A (en) 2003-08-12 2006-10-17 Hoffmann La Roche compounds, process for their preparation, pharmaceutical composition comprising them, use of a compound, methods for the treatment and prophylaxis of arthritis, diabetes, eating disorders and obesity
RU2506267C2 (en) 2008-03-31 2014-02-10 Дженентек, Инк. Benzopyrazine and benzoxepine pi3k inhibitors and use thereof
EP2404902A1 (en) 2009-03-05 2012-01-11 Shionogi&Co., Ltd. Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
AU2010299820A1 (en) * 2009-09-28 2012-04-19 F. Hoffmann-La Roche Ag Benzoxepin PI3K inhibitor compounds and methods of use
ES2444779T3 (en) 2009-09-28 2014-02-26 F. Hoffmann-La Roche Ag Benzoxazepine compounds PI3K inhibitors and their use in cancer treatment
RU2013143747A (en) 2011-03-21 2015-04-27 Ф. Хоффманн-Ля Рош Аг BENZOXAZEPINE COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF APPLICATION
AR089999A1 (en) 2012-02-17 2014-10-01 Hoffmann La Roche TRICYCLE COMPOUNDS AND METHODS FOR THE USE OF THE SAME

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19824175A1 (en) * 1998-05-29 1999-12-02 Novartis Ag Amino azole compounds
DE19908537A1 (en) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Use of polycyclic 2-amino-thiazole systems for the preparation of medicaments for the prophylaxis or treatment of obesity
DK1194421T3 (en) * 1999-06-30 2006-02-13 Lundbeck & Co As H Selective NPY (Y5) antagonists

Also Published As

Publication number Publication date
WO2001064675A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
TWI316062B (en) Anti-inflammatory compounds and uses thereof
AU2001294547A1 (en) Substituted urea neuropeptide y y5 receptor antagonists
HUP0500880A2 (en) Cxcr3 antagonists and pharmaceutical compositions thereof
HUP0301201A3 (en) Methods and compositions utilizing quinazolinones
AU2001294814A1 (en) Pumpcn compositions and uses thereof
IL138471A0 (en) Novel semiconductor materials and their uses
AU2002235224A1 (en) Muscarinic antagonists
IL152700A0 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001246494A1 (en) Condensed thiazolamines and their use as neuropeptide y5 antagonists
GB0101035D0 (en) Formulation and use thereof
AU2001234741A1 (en) Integrin antagonists
GB0026467D0 (en) Compound, composition and use
SG100745A1 (en) Ceramic composition and ceramic capacitor
AU2001276461A1 (en) Cleaning compositions and their use
HUP0401535A3 (en) Somatostatin antagonists and their use
HUP0300050A3 (en) Detergent composition and its use
HUP0303936A3 (en) Novel composition and use
AU2001276258A1 (en) Ceramic component and the use thereof
GB2379320B (en) Street furniture or the like
GB0007530D0 (en) Trityl-type compounds and their use
GB0021497D0 (en) Compounds and their use
AU2002224825A1 (en) Substituted amidoalkyl uracils and the use thereof
GB0005301D0 (en) Compound, composition and use